Industry News
Biotechnology Industry News

CAMP4 poaches Translate Bio medical chief, adds ex-Biogen R&D leader Al Sandrock to advisory board
CAMP4 poaches Translate Bio medical chief, adds ex-Biogen R&D leader Al Sandrock to advisory board klahucik Mon, 03/14/2022 - 11:22
Ascendis scores in phase 3 trial as it looks to expand endocrine-focused portfolio
Ascendis scores in phase 3 trial as it looks to expand endocrine-focused portfolio mbayer Mon, 03/14/2022 - 09:44
BMS-Nektar’s Opdivo combo fails phase 3 in upset to once-largest licensing deal in biotech history
BMS-Nektar's Opdivo combo fails phase 3 in upset to once-largest licensing deal in biotech history klahucik Mon, 03/14/2022 - 08:18
Long wait for pivotal data on Sanofi’s oral SERD ends in failure
Long wait for pivotal data on Sanofi's oral SERD ends in failure ntaylor Mon, 03/14/2022 - 07:25
BridgeBio plots path to market for muscular dystrophy drug after posting phase 2 data
BridgeBio plots path to market for muscular dystrophy drug after posting phase 2 data ntaylor Mon, 03/14/2022 - 06:33
Nutcracker snags $167M series C to develop ‘push-button’ RNA manufacturing, signs on former Gilead CFO
Nutcracker snags $167M series C to develop 'push-button' RNA manufacturing, signs on former Gilead CFO klahucik Fri, 03/11/2022 - 13:13
Concert tunes pipeline by selling off CNS assets to startup Terran Biosciences
Concert tunes pipeline by selling off CNS assets to startup Terran Biosciences klahucik Fri, 03/11/2022 - 10:46
Immunome’s COVID-19 antibody cocktail back on track for phase 1 after FDA lifts hold
Immunome's COVID-19 antibody cocktail back on track for phase 1 after FDA lifts hold mbayer Fri, 03/11/2022 - 09:34
AbbVie doubles down on Gedeon Richter pact that brought Vraylar to the world
AbbVie doubles down on Gedeon Richter pact that brought Vraylar to the world aarmstrong Fri, 03/11/2022 - 08:56
Histogen seeks to tear up COVID-19 R&D pact and go solo, accuses Amerimmune of failing to push on into phase 2
Histogen seeks to tear up COVID-19 R&D pact and go solo, accuses Amerimmune of failing to push on into phase 2 ntaylor Fri, 03/11/2022 - 06:31
Harpoon drug sunk by modest activity, challenging tolerability, forcing pivot from prostate cancer prospect
Harpoon drug sunk by modest activity, challenging tolerability, forcing pivot from prostate cancer prospect ntaylor Fri, 03/11/2022 - 03:54
Orphazyme on last leg as court-mediated restructuring drives another wave of layoffs
Orphazyme on last leg as court-mediated restructuring drives another wave of layoffs mbayer Thu, 03/10/2022 - 18:31
Chutes & Ladders—Janssen’s US oncology lead jumps to Teon as CEO
Chutes & Ladders—Janssen's US oncology lead jumps to Teon as CEO klahucik Thu, 03/10/2022 - 15:40
Capricor culls COVID-19 vax work but eyes phase 3 for Duchenne therapy
Capricor culls COVID-19 vax work but eyes phase 3 for Duchenne therapy klahucik Thu, 03/10/2022 - 14:07
MorphoSys cans US R&D to consolidate work in Germany, taking $254M charge
MorphoSys cans US R&D to consolidate work in Germany, taking $254M charge mbayer Thu, 03/10/2022 - 13:36
Selecta back in phase 1 gene therapy saddle after clinical hold lift, plans to reboot ‘expeditiously’
Selecta back in phase 1 gene therapy saddle after clinical hold lift, plans to reboot 'expeditiously' mbayer Thu, 03/10/2022 - 10:18
Moderna doses 2nd arm of phase 2 booster study combining Spikevax with omicron-busting shot
Moderna doses 2nd arm of phase 2 booster study combining Spikevax with omicron-busting shot aarmstrong Thu, 03/10/2022 - 09:39
Roche-partnered Scenic Biotech snags $31M to study 3 rare disease drugs
Roche-partnered Scenic Biotech snags $31M to study 3 rare disease drugs klahucik Thu, 03/10/2022 - 09:25
Morningside rolls up a pair of biotechs to birth clinical-phase inflammatory disease player
Morningside rolls up a pair of biotechs to birth clinical-phase inflammatory disease player ntaylor Thu, 03/10/2022 - 09:09
Venatorx hits goal in antibiotic phase 3, clearing path to FDA
Venatorx hits goal in antibiotic phase 3, clearing path to FDA ntaylor Thu, 03/10/2022 - 08:06

